Patient Biospecimens & Data Collection – EU
Researchers
Patient-Powered Biospecimens and Data
Procure Human Biospecimens Prospectively
The ability to access clinically relevant biospecimens and the accompanying patient data is crucial, and often a bottleneck, in translational research. The more specific the patient criteria, the smaller the accessible patient population becomes, resulting in a burdensome study completion.
Sanguine is able to offer a direct-to-patient approach that encompasses the specific patient criteria for your research needs while utilizing our already established patient communities for recruitment. These capabilities can be used in conjunction with sample processing and international shipping services to ensure sample quality and logistical timelines. Sanguine's fully integrated solution combines both study design experience and scientific expertise to provide a simple solution to prospective biospecimen procurement.
1
Disease State and
Study Design
2
Inclusion and
Exclusion Criteria
3
Sample Acquisition
and Scientific
Processing
4
Logistically Sound
Global Shipping
Human Biospecimen Types
Our specimen procurement capabilities are minimally invasive and are further supported by in-home centrifugation, supplementary laboratory services (e.g., isolation of peripheral blood mononuclear cells (PBMCs), HLA typing, comprehensive clinical testing), and temperature-sensitive shipments according to your study protocol.
Blood-Derived Biofluids and Products
Non-Blood-Derived Biofluids
- Nasal mucosa
- Non-induced sputum
- Saliva
- Semen
- Stool
- Urine
Why Sanguine
A custom-tailored approach means an enhanced ability to recruit US based participants and ethically procure biospecimens prospectively. You'll get more accurate data points per sample, increased study design flexibility, and an expedited time to completion.
US-based patient member community to meet complex inclusion/exclusion criteria
Medical record-verified eligibility and pre-screening
Access to electronic medical records, health histories, patient-reported datasets
Recallable study participants
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 70,000 total members ready to advance science and medicine for the conditions they live with.
Get Samples for My Research
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, and International Conference on Harmonization (ICH).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.